Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Infection, Immunological Response, and Vaccine Development
出版年份 2019 全文链接
标题
Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Infection, Immunological Response, and Vaccine Development
作者
关键词
-
出版物
Journal of Immunology Research
Volume 2019, Issue -, Pages 1-11
出版商
Hindawi Limited
发表日期
2019-04-08
DOI
10.1155/2019/6491738
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile
- (2018) Waleed H. Mahallawi et al. CYTOKINE
- MERS-CoV 4b protein interferes with the NF-κB-dependent innate immune response during infection
- (2018) Javier Canton et al. PLoS Pathogens
- Middle east respiratory syndrome corona virus spike glycoprotein suppresses macrophage responses via DPP4-mediated induction of IRAK-M and PPARγ
- (2017) Ahmed A. Al-Qahtani et al. Oncotarget
- The epidemiology of Middle East respiratory syndrome coronavirus in the Kingdom of Saudi Arabia, 2012–2015
- (2016) Abdullah J. Alsahafi et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Viral Shedding and Antibody Response in 37 Patients With Middle East Respiratory Syndrome Coronavirus Infection
- (2015) Victor M. Corman et al. CLINICAL INFECTIOUS DISEASES
- Middle East Respiratory Syndrome Coronavirus: Another Zoonotic Betacoronavirus Causing SARS-Like Disease
- (2015) Jasper F. W. Chan et al. CLINICAL MICROBIOLOGY REVIEWS
- Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus
- (2015) Xiaojuan Guo et al. IMMUNOLOGY
- Discovery of T-Cell Infection and Apoptosis by Middle East Respiratory Syndrome Coronavirus
- (2015) Tianlei Ying et al. JOURNAL OF INFECTIOUS DISEASES
- Middle East Respiratory Syndrome Coronavirus Efficiently Infects Human Primary T Lymphocytes and Activates the Extrinsic and Intrinsic Apoptosis Pathways
- (2015) Hin Chu et al. JOURNAL OF INFECTIOUS DISEASES
- Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein
- (2015) Asisa Volz et al. JOURNAL OF VIROLOGY
- Generation of a Transgenic Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and Disease
- (2015) Anurodh Shankar Agrawal et al. JOURNAL OF VIROLOGY
- Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection
- (2015) Kristen E. Pascal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Middle East respiratory syndrome coronavirus infection: virus-host cell interactions and implications on pathogenesis
- (2015) Jie Zhou et al. Virology Journal
- Receptor-binding domain-based subunit vaccines against MERS-CoV
- (2015) Naru Zhang et al. VIRUS RESEARCH
- Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection
- (2015) Allison L. Totura et al. mBio
- Optimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus
- (2015) Jian Tang et al. Human Vaccines & Immunotherapeutics
- Current advancements and potential strategies in the development of MERS-CoV vaccines
- (2014) Naru Zhang et al. Expert Review of Vaccines
- T cell-mediated immune response to respiratory coronaviruses
- (2014) Rudragouda Channappanavar et al. IMMUNOLOGIC RESEARCH
- Intranasal Vaccination of Recombinant Adeno-Associated Virus Encoding Receptor-Binding Domain of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Spike Protein Induces Strong Mucosal Immune Responses and Provides Long-Term Protection against SARS-CoV Infection
- (2014) L. Du et al. JOURNAL OF IMMUNOLOGY
- Middle East Respiratory Syndrome Coronavirus 4a Protein Is a Double-Stranded RNA-Binding Protein That Suppresses PACT-Induced Activation of RIG-I and MDA5 in the Innate Antiviral Response
- (2014) K.-L. Siu et al. JOURNAL OF VIROLOGY
- Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trial
- (2014) Joost H C M Kreijtz et al. LANCET INFECTIOUS DISEASES
- Distinct Immune Response in Two MERS-CoV-Infected Patients: Can We Go from Bench to Bedside?
- (2014) Emmanuel Faure et al. PLoS One
- Rapid generation of a mouse model for Middle East respiratory syndrome
- (2014) Jincun Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments—The importance of immunofocusing in subunit vaccine design
- (2014) Cuiqing Ma et al. VACCINE
- Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines
- (2014) Cuiqing Ma et al. VACCINE
- Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice
- (2014) Christopher M. Coleman et al. VACCINE
- Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response
- (2014) Hin Chu et al. VIROLOGY
- Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein
- (2014) Shuai Xia et al. VIRUS RESEARCH
- Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases
- (2014) Arwen Altenburg et al. Viruses-Basel
- Middle East Respiratory Syndrome Coronavirus Infection in Dromedary Camels in Saudi Arabia
- (2014) A. N. Alagaili et al. mBio
- Interferon- and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays
- (2013) B. J. Hart et al. JOURNAL OF GENERAL VIROLOGY
- MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon- treatment
- (2013) A. H. de Wilde et al. JOURNAL OF GENERAL VIROLOGY
- Antibodies induced by receptor-binding domain in spike protein of SARS-CoV do not cross-neutralize the novel human coronavirus hCoV-EMC
- (2013) Lanying Du et al. JOURNAL OF INFECTION
- Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests
- (2013) Kwok-Hung Chan et al. JOURNAL OF INFECTION
- Active Replication of Middle East Respiratory Syndrome Coronavirus and Aberrant Induction of Inflammatory Cytokines and Chemokines in Human Macrophages: Implications for Pathogenesis
- (2013) Jie Zhou et al. JOURNAL OF INFECTIOUS DISEASES
- Middle East Respiratory Syndrome Coronavirus Spike Protein Delivered by Modified Vaccinia Virus Ankara Efficiently Induces Virus-Neutralizing Antibodies
- (2013) F. Song et al. JOURNAL OF VIROLOGY
- The Receptor Binding Domain of the New Middle East Respiratory Syndrome Coronavirus Maps to a 231-Residue Region in the Spike Protein That Efficiently Elicits Neutralizing Antibodies
- (2013) H. Mou et al. JOURNAL OF VIROLOGY
- Tropism of and Innate Immune Responses to the Novel Human Betacoronavirus Lineage C Virus in Human Ex Vivo Respiratory Organ Cultures
- (2013) R. W. Y. Chan et al. JOURNAL OF VIROLOGY
- Identification of a Receptor-Binding Domain in the S Protein of the Novel Human Coronavirus Middle East Respiratory Syndrome Coronavirus as an Essential Target for Vaccine Development
- (2013) L. Du et al. JOURNAL OF VIROLOGY
- Human Cell Tropism and Innate Immune System Interactions of Human Respiratory Coronavirus EMC Compared to Those of Severe Acute Respiratory Syndrome Coronavirus
- (2013) F. Zielecki et al. JOURNAL OF VIROLOGY
- Middle East Respiratory Syndrome Coronavirus Accessory Protein 4a Is a Type I Interferon Antagonist
- (2013) D. Niemeyer et al. JOURNAL OF VIROLOGY
- Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study
- (2013) Matthew Cotten et al. LANCET
- Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk
- (2013) Romulus Breban et al. LANCET
- Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26
- (2013) Guangwen Lu et al. NATURE
- A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines
- (2013) Lanying Du et al. PLoS One
- Cell Host Response to Infection with Novel Human Coronavirus EMC Predicts Potential Antivirals and Important Differences with SARS Coronavirus
- (2013) L. Josset et al. mBio
- The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists
- (2013) Yang Yang et al. Protein & Cell
- IL-17 cytokines in immunity and inflammation
- (2013) Wei Jin et al. Emerging Microbes & Infections
- A tale of two cytokines: IL-17 and IL-22 in asthma and infection
- (2013) Michelle L Manni et al. Expert Review of Respiratory Medicine
- Dendritic Cells: A Spot on Sialic Acid
- (2013) Hélio J. Crespo et al. Frontiers in Immunology
- Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome
- (2012) Shibo Jiang et al. Expert Review of Vaccines
- Clusters of coronavirus cases put scientists on alert
- (2012) Declan Butler NATURE
- Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
- (2012) Ali M. Zaki et al. NEW ENGLAND JOURNAL OF MEDICINE
- NK cells controlling virus-specific T cells: Rheostats for acute vs. persistent infections
- (2012) Raymond M. Welsh et al. VIROLOGY
- ISCOM technology-based Matrix M™ adjuvant: success in future vaccines relies on formulation
- (2011) Karin Lövgren Bengtsson et al. Expert Review of Vaccines
- Mycophenolic acid augments interferon-stimulated gene expression and inhibits hepatitis C Virus infection in vitro and in vivo
- (2011) Qiuwei Pan et al. HEPATOLOGY
- RIG-I-like receptors: cytoplasmic sensors for non-self RNA
- (2011) Hiroki Kato et al. IMMUNOLOGICAL REVIEWS
- Lack of Peripheral Memory B Cell Responses in Recovered Patients with Severe Acute Respiratory Syndrome: A Six-Year Follow-Up Study
- (2011) F. Tang et al. JOURNAL OF IMMUNOLOGY
- Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV
- (2011) Ye V. Liu et al. VACCINE
- Evaluation of a virosomal H5N1 vaccine formulated with Matrix M™ adjuvant in a phase I clinical trial
- (2011) Rebecca J. Cox et al. VACCINE
- IL-10 family of cytokines
- (2010) Robert Sabat CYTOKINE & GROWTH FACTOR REVIEWS
- TLR-signaling Networks
- (2010) J. Brown et al. JOURNAL OF DENTAL RESEARCH
- Toll-like receptors and innate immunity
- (2009) Himanshu Kumar et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Effect of Preexisting Immunity on an Adenovirus Vaccine Vector: In Vitro Neutralization Assays Fail To Predict Inhibition by Antiviral Antibody In Vivo
- (2009) S. L. Pichla-Gollon et al. JOURNAL OF VIROLOGY
- The spike protein of SARS-CoV — a target for vaccine and therapeutic development
- (2009) Lanying Du et al. NATURE REVIEWS MICROBIOLOGY
- MyD88 Is Required for Protection from Lethal Infection with a Mouse-Adapted SARS-CoV
- (2008) Timothy Sheahan et al. PLoS Pathogens
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More